Stockholders' Equity (Capital Raises) (Narrative) (Details) - USD ($)
|
|
|
|
|
|
1 Months Ended |
9 Months Ended |
|
|
|
|
Jun. 12, 2024 |
Jan. 05, 2024 |
May 05, 2023 |
Dec. 30, 2022 |
Apr. 23, 2021 |
Sep. 30, 2024 |
Jul. 31, 2024 |
Jun. 30, 2024 |
May 31, 2024 |
Apr. 30, 2024 |
Jan. 31, 2024 |
Sep. 30, 2024 |
Sep. 30, 2023 |
Jan. 09, 2024 |
Dec. 31, 2023 |
Nov. 02, 2023 |
Oct. 11, 2022 |
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stock offering, number of shares issued |
|
|
|
4,900,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Gross proceeds |
|
|
|
|
|
$ 7,400,000
|
|
|
|
|
|
|
|
|
|
|
|
Common Stock, par value |
|
|
|
$ 0.0001
|
|
$ 0.001
|
|
|
|
|
|
$ 0.001
|
|
|
$ 0.001
|
|
|
Warrants exercised, Number of shares |
|
|
|
|
|
|
|
|
|
|
|
(17,500)
|
|
|
|
|
|
Sale of stock, net proceeds |
|
|
|
$ 150,000,000.0
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Exercise of warrants for cash |
|
|
|
|
|
|
|
|
|
|
|
$ 30,000
|
$ 0
|
|
|
|
|
November 2023 Warrants |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Exercise price of warrants |
|
|
|
|
|
1.65
|
|
|
|
|
|
$ 1.65
|
|
|
|
|
|
Unit Price Per Share |
|
|
|
|
|
$ 1.70
|
|
|
|
|
|
$ 1.70
|
|
|
|
|
|
Number of warrants issued |
|
|
|
|
|
5,885,000
|
|
|
|
|
|
5,885,000
|
|
|
|
|
|
Private Placement Warrants |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Exercise price of warrants |
|
|
|
|
|
$ 1.84
|
|
|
|
|
|
$ 1.84
|
|
|
|
|
|
Concurrent Private Placement Warrants | Chief Executive Officer (Dr. Rosenwald) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Shares issued |
|
|
|
|
|
763,359
|
|
|
|
|
|
|
|
|
|
|
|
Shares issued, price per share |
|
|
|
|
|
$ 1.84
|
|
|
|
|
|
$ 1.84
|
|
|
|
|
|
Avenue |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Number of warrants to purchase shares |
|
|
|
|
|
|
|
|
|
689,680
|
|
|
|
|
|
|
|
Exercise price of warrants |
|
|
|
|
|
|
|
|
|
$ 6.20
|
|
|
|
|
|
|
$ 116.25
|
Avenue | Series A Warrants |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stock offering, price per share |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 22.545
|
|
Avenue | Series B Warrants |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stock offering, price per share |
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 22.545
|
|
|
|
Avenue | Unregistered warrants |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Number of warrants to purchase shares |
|
|
|
|
|
|
|
|
|
1,379,360
|
|
|
|
|
|
|
|
Stock offering, price per share |
|
|
|
|
|
|
|
|
|
$ 0.125
|
|
|
|
|
|
|
|
Exercise price of warrants |
|
|
|
|
|
|
|
|
|
$ 6.20
|
|
|
|
|
|
|
|
Net proceeds |
|
|
|
|
|
|
|
|
$ 3,900,000
|
$ 3,700,000
|
|
|
|
|
|
|
|
Fair value of warrants |
|
|
|
|
|
|
|
|
|
$ 4,500,000
|
|
|
|
|
|
|
|
Maximum | Private Placement Warrants |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Number of shares called by warrants |
|
|
|
|
|
3,939,394
|
|
|
|
|
|
3,939,394
|
|
|
|
|
|
Warrant expiration term |
|
|
|
|
|
5 years 6 months
|
|
|
|
|
|
5 years 6 months
|
|
|
|
|
|
Maximum | Concurrent Private Placement Warrants | Chief Executive Officer (Dr. Rosenwald) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Number of shares called by warrants |
|
|
|
|
|
763,359
|
|
|
|
|
|
763,359
|
|
|
|
|
|
Warrant expiration term |
|
|
|
|
|
5 years 6 months
|
|
|
|
|
|
5 years 6 months
|
|
|
|
|
|
Maximum | Avenue |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Warrant expiration term |
|
|
|
|
|
|
|
|
|
5 years
|
|
|
|
|
|
|
|
Minimum | Private Placement Warrants |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Warrant expiration term |
|
|
|
|
|
6 months
|
|
|
|
|
|
6 months
|
|
|
|
|
|
Minimum | Concurrent Private Placement Warrants | Chief Executive Officer (Dr. Rosenwald) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Warrant expiration term |
|
|
|
|
|
6 months
|
|
|
|
|
|
6 months
|
|
|
|
|
|
Minimum | Avenue |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Warrant expiration term |
|
|
|
|
|
|
|
|
|
18 months
|
|
|
|
|
|
|
|
At the Market Offering |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stock offering, number of shares issued |
|
|
|
|
|
|
|
|
|
|
|
1,800,000
|
200,000
|
|
|
|
|
Stock offering, price per share |
|
|
|
|
|
$ 1.95
|
|
|
|
|
|
$ 1.95
|
$ 9.61
|
|
|
|
|
Stock offering, gross proceeds |
|
|
|
|
|
|
|
|
|
|
|
$ 3,500,000
|
$ 2,200,000
|
|
|
|
|
At the Market Offering | Journey |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stock offering, number of shares issued |
|
|
|
|
|
|
|
|
|
|
|
300,000
|
|
|
|
|
|
Number of Shares issuable for At-the-Market offering |
|
|
|
|
|
|
|
|
|
|
|
3.8
|
|
|
|
|
|
Stock offering, gross proceeds |
|
|
|
|
|
|
|
|
|
|
|
$ 1,700,000
|
|
|
|
|
|
At the Market Offering | Checkpoint | Founders Agreement |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stock offering, number of shares issued |
|
|
|
|
|
|
|
|
|
|
|
340,246
|
|
|
|
|
|
Shares issued (in percent) |
|
|
|
|
|
|
|
|
|
|
|
2.50%
|
|
|
|
|
|
At the Market Offering | Avenue | Founders Agreement |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stock offering, number of shares issued |
|
|
|
|
|
|
|
|
|
|
|
25,567
|
|
|
|
|
|
Number of shares available for future issuance |
|
|
|
|
|
4,023
|
|
|
|
|
|
4,023
|
|
|
|
|
|
At the Market Offering | Avenue | Unregistered warrants |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Number of warrants to purchase shares |
|
|
|
|
|
245,617
|
|
|
|
|
|
245,617
|
|
|
|
|
|
Net proceeds |
|
|
|
|
|
|
|
|
|
|
|
$ 900,000
|
|
|
|
|
|
Public Offering | Mustang |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stock offering, number of shares issued |
|
|
|
|
|
|
|
|
1,160,000
|
|
|
|
|
|
|
|
|
Number of warrants to purchase shares |
|
|
|
|
|
|
|
|
50,632,914
|
|
|
|
|
|
|
|
|
Stock offering, price per share |
|
|
|
|
|
|
|
|
$ 0.237
|
|
|
|
|
|
|
|
|
Exercise price of warrants |
|
|
|
|
|
|
|
|
$ 0.237
|
|
|
|
|
|
|
|
|
Warrants exercised, Number of shares |
|
|
|
|
|
|
|
|
15,717,638
|
|
|
|
|
|
|
|
|
Exercise of warrants for cash |
|
|
|
|
|
|
|
|
$ 3,200,000
|
|
|
|
|
|
|
|
|
Public Offering | Mustang | Series A One Warrants |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Warrant expiration term |
|
|
|
|
|
|
|
|
5 years
|
|
|
|
|
|
|
|
|
Public Offering | Mustang | Series A Two Warrants |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Warrant expiration term |
|
|
|
|
|
|
|
|
24 months
|
|
|
|
|
|
|
|
|
Public Offering | Mustang | Series A Three Warrants |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Warrant expiration term |
|
|
|
|
|
|
|
|
9 months
|
|
|
|
|
|
|
|
|
Public Offering | Mustang | Amended Warrants |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Number of warrants to purchase shares |
|
|
|
|
|
|
|
|
2,588,236
|
|
|
|
|
|
|
|
|
Stock offering, price per share |
|
|
|
|
|
|
|
|
$ 1.58
|
|
|
|
|
|
|
|
|
Exercise price of warrants |
|
|
|
|
|
|
|
|
$ 0.237
|
|
|
|
|
|
|
|
|
Warrant expiration term |
|
|
|
|
|
|
|
|
5 years
|
|
|
|
|
|
|
|
|
Public Offering | Mustang | Common Stock |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stock offering, number of shares issued |
|
|
|
|
|
|
|
|
16,877,638
|
|
|
|
|
|
|
|
|
Shelf Registration 2020 Statement | Checkpoint |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Amount available for future stock offerings |
|
|
|
|
|
$ 0
|
|
|
|
|
|
0
|
|
|
|
|
|
Shelf Registration 2023 Statement | Checkpoint |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Amount available for future stock offerings |
|
|
|
|
|
65,700,000
|
|
|
|
|
|
65,700,000
|
|
|
|
|
|
Shelf Registration 2023 Statement | Maximum | Checkpoint |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stock offering, aggregate offering permitted by the agreement |
|
|
$ 150,000,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Shelf Registration 2024 Statement |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Amount available for future stock offerings |
|
|
|
|
|
43,500,000
|
|
|
|
|
|
43,500,000
|
|
|
|
|
|
Shelf Registration 2024 Statement | Mustang |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stock offering, aggregate offering permitted by the agreement |
|
|
|
|
|
|
|
|
|
|
|
36,300,000
|
|
|
|
|
|
Shelf Registration 2024 Statement | Maximum | Mustang |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stock offering, aggregate offering permitted by the agreement |
$ 40,000,000.0
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Shelf Registration 2021 Statement |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Amount available for future stock offerings |
|
|
|
|
|
0
|
|
|
|
|
|
$ 0
|
|
|
|
|
|
Shelf Registration 2021 Statement | Mustang |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stock offering, number of shares issued |
|
|
|
|
|
|
|
|
|
|
|
2,700,000
|
|
|
|
|
|
Stock offering, aggregate offering permitted by the agreement |
|
|
|
|
$ 200,000,000.0
|
|
|
|
|
|
|
$ 4,400,000
|
|
|
|
|
|
Sale of stock, net proceeds |
|
|
|
|
|
|
|
|
|
|
|
1,200,000
|
|
|
|
|
|
Shelf Registration 2021 Statement | Avenue |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Amount available for future stock offerings |
|
|
|
|
|
$ 24,100,000
|
|
|
|
|
|
$ 24,100,000
|
|
|
|
|
|
Direct offering |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stock offering, number of shares issued |
|
|
|
|
|
3,939,394
|
|
|
|
|
3,303,305
|
|
|
|
|
|
|
Shares issued, price per share |
|
|
|
|
|
$ 1.65
|
|
|
|
|
|
$ 1.65
|
|
|
|
|
|
Exercise price of warrants |
|
|
|
|
|
|
|
|
|
|
$ 3.21
|
|
|
|
|
|
|
Unit Price Per Share |
|
|
|
|
|
|
|
|
|
|
$ 3.33
|
|
|
|
|
|
|
Warrant expiration term |
|
|
|
|
|
|
|
|
|
|
5 years
|
|
|
|
|
|
|
Sale of stock, net proceeds |
|
|
|
|
|
|
|
|
|
|
$ 10,200,000
|
|
|
|
|
|
|
Direct offering | Checkpoint |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Issuance of common shares - Registered direct offering |
|
|
|
|
|
|
1,230,000
|
|
|
|
1,275,000
|
|
|
|
|
|
|
Stock offering, price per share |
|
|
|
|
|
|
$ 2.05
|
|
|
|
$ 1.805
|
|
|
|
|
|
|
Sale of stock, net proceeds |
|
|
|
|
|
|
$ 11,000,000.0
|
|
|
|
$ 12,600,000
|
|
|
|
|
|
|
Direct offering | Checkpoint | Common Stock Warrant |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Exercise price of warrants |
|
|
|
|
|
|
$ 2.05
|
|
|
|
$ 1.68
|
|
|
|
|
|
|
Warrant expiration term |
|
|
|
|
|
|
5 years
|
|
|
|
5 years
|
|
|
|
|
|
|
Direct offering | Checkpoint | Pre funded warrants |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Warrants issued |
|
|
|
|
|
|
4,623,659
|
|
|
|
6,481,233
|
|
|
|
|
|
|
Number of shares called by warrants |
|
|
|
|
|
|
|
|
|
|
1
|
|
|
|
|
|
|
Stock offering, price per share |
|
|
|
|
|
|
$ 2.0499
|
|
|
|
$ 1.8049
|
|
|
|
|
|
|
Exercise price of warrants |
|
|
|
|
|
|
|
|
|
|
0.0001
|
|
|
|
|
|
|
Direct offering | Checkpoint | Placement Agent Warrants |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Number of shares called by warrants |
|
|
|
|
|
|
351,220
|
|
|
|
|
|
|
|
|
|
|
Exercise price of warrants |
|
|
|
|
|
|
$ 2.5625
|
|
|
|
$ 2.2563
|
|
|
|
|
|
|
Direct offering | Mustang |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stock offering, number of shares issued |
|
|
|
|
|
|
|
3,025,000
|
|
|
|
641,740
|
|
|
|
|
|
Number of warrants to purchase shares |
|
|
|
|
|
|
|
3,105,000
|
|
|
|
|
|
|
|
|
|
Stock offering, price per share |
|
|
|
|
|
|
|
$ 0.4099
|
|
|
|
|
|
|
|
|
|
Per share amount reduced from share price to calculate warrant price |
|
|
|
|
|
|
|
0.001
|
|
|
|
|
|
|
|
|
|
Exercise price of warrants |
|
|
|
|
|
|
|
$ 0.001
|
|
|
|
|
|
|
|
|
|
Warrant expiration term |
|
|
|
|
|
|
|
5 years
|
|
|
|
|
|
|
|
|
|
Warrants exercised, Number of shares |
|
|
|
|
|
|
|
3,105,000
|
|
|
|
|
|
|
|
|
|
Sale of stock, net proceeds |
|
|
|
|
|
|
|
$ 2,100,000
|
|
|
|
|
|
|
|
|
|
Shares issued (in percent) |
|
|
|
|
|
|
|
2.50%
|
|
|
|
|
|
|
|
|
|
Direct offering | Mustang | Unregistered warrants |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Number of warrants to purchase shares |
|
|
|
|
|
|
|
6,130,000
|
|
|
|
|
|
|
|
|
|
Exercise price of warrants |
|
|
|
|
|
|
|
$ 0.41
|
|
|
|
|
|
|
|
|
|
Direct offering | Maximum |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Number of warrants to purchase shares |
|
|
|
|
|
|
|
|
|
|
3,303,305
|
|
|
|
|
|
|
Direct offering | Maximum | Checkpoint |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Number of shares called by warrants |
|
|
|
|
|
|
5,853,659
|
|
|
|
|
|
|
|
|
|
|
Number of warrants to purchase shares |
|
|
|
|
|
|
|
|
|
|
7,756,233
|
|
|
|
|
|
|
Direct offering | Maximum | Checkpoint | Placement Agent Warrants |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Number of warrants to purchase shares |
|
|
|
|
|
|
|
|
|
|
465,374
|
|
|
|
|
|
|
Private Placement | Avenue |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Exercise of warrants for cash |
|
$ 4,500,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Private Placement | Avenue | Series A Warrants |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Number of warrants to purchase shares |
|
220,538
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Private Placement | Avenue | Series B Warrants |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Number of warrants to purchase shares |
|
220,538
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Private Placement | Avenue | January 2023 Warrants |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Number of warrants to purchase shares |
|
25,871
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Exercise price of warrants |
|
$ 116.25
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Exercise price of warrants agreed by investor |
|
$ 22.545
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Fair value of warrants |
|
|
|
|
|
$ 600,000
|
|
|
|
|
|
$ 600,000
|
|
|
|
|
|
Private Placement | Avenue | November 2023 Warrants |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Number of warrants to purchase shares |
|
194,667
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Exercise price of warrants |
|
$ 22.545
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Exercise price of warrants agreed by investor |
|
$ 22.545
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Fair value of warrants |
|
|
|
|
|
$ 4,300,000
|
|
|
|
|
|
$ 4,300,000
|
|
|
|
|
|
Concurrent Private Placement | Chief Executive Officer (Dr. Rosenwald) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Shares issued, price per share |
|
|
|
|
|
$ 1.84
|
|
|
|
|
|
$ 1.84
|
|
|
|
|
|
Exercise price of warrants |
|
|
|
|
|
$ 0.125
|
|
|
|
|
|
$ 0.125
|
|
|
|
|
|